FrancophonIA/ELRC3.0 huggingface dataset:
English: In women who do not use a CHC and are not pregnant about 2 out of 10,000 will develop a VTE over the period of one year.
Slovenian: Pri približno 2 od 10.000 žensk, ki ne uporabljajo CHC in niso noseče, se bo v enem letu pojavila VTE.
English: Positive family history (venous thromboembolism ever in a sibling or parent at relatively early age)
Slovenian: Pozitivna družinska anamneza (venska trombembolija kadar koli pri sorojencu ali staršu v sorazmerno zgodnji starosti, npr. pred 50 letom).
English: • chest pain, discomfort, pressure, heaviness;
Slovenian: • bolečine v prsih, nelagodje, pritisk, občutek teže
English: • You must use non-hormonal contraception as back up for one week.
Slovenian: • En teden morate kot dodatno zaščito uporabljati nehormonsko kontracepcijo.
English: The next EVRA transdermal patch should be applied on the usual “Change Day”.
Slovenian: Naslednji transdermalni obliž EVRA mora namestiti na običajen “dan zamenjave”.
English: The increased risk of VTE during the postpartum period should be considered when re-starting EVRA (see sections 4.2 and 4.4).
Slovenian: Ob ponovni uporabi obliža EVRA po porodu je treba upoštevati povečano tveganje za VTE (glejte poglavji 4.2 in 4.4).
English: Extremely rarely, thrombosis has been reported to occur in CHC users in other blood vessels, e.g. hepatic, mesenteric, renal or retinal veins and arteries.
Slovenian: Izredno redko so pri ženskah, ki so jemale CHC, poročali o trombozi v drugih žilah, npr. jetrnih, mezenteričnih, ledvičnih ali mrežničnih venah in arterijah.
English: If any of the above conditions change while you are using EVRA, for example you start smoking, a close family member experiences a thrombosis for no known reason; or you gain a lot of weight, tell your doctor.
Slovenian: Če se med uporabo zdravila EVRA kateri od zgoraj navedenih pogojev spremeni, na primer da začnete kaditi ali dobi bližnji sorodnik trombozo zaradi neznanega razloga, ali če se močno zredite, posvetujte se z zdravnikom.
English: • Firmly grasp a corner of the patch and gently take it from the foil sachet
Slovenian: • Trdno primite vogal obliža in ga previdno vzemite iz blazinice.
English: Obesity (body mass index over 30 kg/m²)
Slovenian: Debelost (indeks telesne mase več kot 30 kg/m²)
English: Users who choose not to breast-feed should start contraceptive therapy with EVRA no sooner than 4 weeks after child-birth.
Slovenian: Ženske, ki se odločijo, da ne bodo dojile, se lahko z obližem EVRA zaščitijo pred nosečnostjo šele 4 tedne po rojstvu otroka.
English: - The following conditions have been reported to occur or deteriorate with both pregnancy and COC use, but the evidence of an association with COC use is inconclusive: Jaundice and/or pruritus related to cholestasis; gallbladder disease including cholecystitis and cholelithiasis; porphyria; systemic lupus erythematosus; haemolytic ureamic syndrome; Sydenham's chorea; herpes gestationis; otosclerosis-related hearing loss.
Slovenian: - Poročali so, da se tako med nosečnostjo kot tudi med jemanjem KPKS naslednja stanja bodisi pojavijo bodisi poslabšajo, niso pa dokazali, da so povezana z jemanjem KPKS: zlatenica in/ali pruritus, povezan s holestazo, bolezni žolčnika, vključno s holecistitisom in holelitiazo, porfirija, sistemski lupus eritematozus, hemolitičnouremični sindrom, Sydenhamova horea, pemfigoid (herpes gestationis), izguba sluha povezana z otosklerozo.
English: Female contraception
Slovenian: Kontracepcija za ženske.
English: • Venous thromboembolism - current VTE (on anticoagulants) or history of (e.g. deep venous thrombosis [DVT] or pulmonary embolism [PE]);
Slovenian: • Venska trombembolija - obstoječa VTE (zdravljena z antikoagulanti) ali v anamnezi (npr. globoka venska tromboza [DVT, deep venous thrombosis] ali pljučna embolija [PE]).
English: • The day you apply your first patch will be Day 1.
Slovenian: • Dan, ko namestite prvi obliž, je dan 1.
English: In order to postpone a menstrual period for one cycle, the woman must apply another transdermal patch at the beginning of Week 4 (Day 22) thus not observing the transdermal patch-free interval.
Slovenian: Če želi ženska menstruacijo preložiti za en cikel, mora naslednji transdermalni obliž namestiti na začetku 4. tedna (22. dan) in ne upoštevati obdobja premora.
English: After 10 years, the risk is the same as for people who have never used the combined hormonal contraceptive.
Slovenian: Po desetih letih je možnost nastanka raka dojke enaka kot pri ženskah, ki niso nikoli jemale kombiniranih hormonskih kontraceptivov.
English: • Abnormal cells in your cervix
Slovenian: • nenormalne celice v materničnem vratu
English: Risk increases substantially as BMI rises.
Slovenian: Tveganje se z večanjem indeksa telesne mase bistveno poveča.
English: • Never go without wearing a patch for more than 7 days in a row.
Slovenian: • Obdobje, ko ne nosite obliža, ne sme trajati več kot 7 dni.
English: If the user wishes to move the Change Day the current cycle should be completed, removing the third EVRA transdermal patch on the correct day.
Slovenian: Če želi ženska premakniti dan zamenjave, mora biti trenutni cikel zaključen (tretji transdermalni obliž EVRA odstrani na dan, ki je za to določen).
English: The decision to prescribe EVRA should take into consideration the individual woman's current risk factors, particularly those for venous thromboembolism (VTE), and how the risk of VTE with EVRA compares with other CHCs (see sections 4.3 and 4.4).
Slovenian: Ob odločitvi za predpisovanje zdravila EVRA je treba upoštevati obstoječe dejavnike tveganja za vsako posamično žensko, zlasti za vensko trombembolijo (VTE), in kakšno je tveganje za VTE z zdravilom EVRA v primerjavi s tveganjem pri drugih kombiniranih hormonskih kontraceptivih (CHC, combined hormonal contraceptives (glejte poglavji 4.3 in 4.4).
English: • History of migraine with focal neurological symptoms;
Slovenian: • Migrene z žariščnimi nevrološkimi simptomi v anamnezi.
English: • if you have haemolytic uraemic syndrome (HUS - a disorder of blood clotting causing failure of the kidneys);
Slovenian: • če imate hemolitično uremični sindrome (motnja strjevanja krvi, ki povzroča odpoved ledvic);
English: The risk of ovulation increases with each day beyond the recommended contraceptive-free period.
Slovenian: Tveganje za ovulacijo se povečuje z vsakim dnem, ko ženska prekorači priporočeno obdobje premora, v katerem transdermalnega obliža ne uporablja.
English: • Do not put the patch on skin that is red, irritated or cut.
Slovenian: • Izogibajte se namestitvi obliža na kožo, ki je pordela, razdražena ali poškodovana.
English: • swelling of one leg or along a vein in the leg or foot especially when accompanied by: - pain or tenderness in the leg which may be felt only when standing or walking; - increased warmth in the affected leg; - change in colour of the skin on the leg e.g. turning pale, red or blue.
Slovenian: • oteklost ene noge ali vzdolž vene v nogi ali stopalu, zlasti, če jo spremlja: - bolečina ali občutljivost nog, ki se lahko čuti le stoje ali med hojo - povečan občutek toplote v prizadeti nogi - spremenjena barva kože na nogi, npr. bledica, rdečina ali modrikavost kože globoka venska tromboza
English: The woman may switch any day from the progestogen-only pill (from an implant on the day of its removal, from an injectable when the next injection would be due), but a back-up barrier method of birth control must be used during the first 7 days.
Slovenian: Uporaba obliža namesto metode, pri kateri uporabljamo le progestogen Ženska lahko začne namesto tablet progestogena (pri implantatu na dan njegove odstranitve, pri injekciji pa takrat, ko bi morala dobiti naslednjo) obliž uporabljati kadarkoli, vendar pa mora prvih 7 dni sočasno uporabljati še mehansko kontracepcijsko metodo.
English: Thin, matrix-type transdermal patch consisting of three layers.
Slovenian: Tanek transdermalni obliž matriksnega tipa iz treh plasti.
English: If you have trouble remembering to change your patch
Slovenian: Če si težko zapomnite, kdaj morate zamenjati obliž EVRA
English: Whether this is also applies to the lower dosed combined hormonal contraceptives remains to be confirmed.
Slovenian: Treba pa bo še potrditi, ali to velja tudi za nižje odmerke kombiniranih hormonskih kontraceptivov.
English: The risk of developing a blood clot increases the more conditions you have.
Slovenian: Tveganje za nastanek krvnega strdka se veča s številom stanj.
English: - Out of 10,000 women who are using a combined hormonal contraceptive that contains levonorgestrel, norethisterone, or norgestimate about 5-7 will develop a blood clot in a year.
Slovenian: • Na 10.000 žensk, ki uporabljajo kombinirani hormonski kontraceptiv, ki vsebuje levonorgestrel ali noretisteron ali norgestimat, se bo krvni strdek razvil pri približno 5-7 ženskah na leto.
English: When starting later, the woman should be advised to additionally use a barrier method for the first 7 days.
Slovenian: Če ženska začne obliž uporabljati kasneje, ji moramo svetovati, da v prvih 7 dneh sočasno uporablja še mehansko kontracepcijsko metodo.
English: - Out of 10,000 women who are using a combined hormonal contraceptive that contains etonorgestrel or norelgestromin such as EVRA between about 6 and 12 women will develop a blood clot in a year.
Slovenian: • Na 10.000 žensk, ki uporabljajo kombinirani hormonski kontraceptiv, ki vsebuje etonorgestrel ali norelgestromin, kot je zdravilo EVRA, se bo krvni strdek razvil pri približno 6 in 12 ženskami na leto.
English: Symptoms of pulmonary embolism (PE) can include: - sudden onset of unexplained shortness of breath or rapid breathing; - sudden coughing which may associated with haemoptysis; - sharp chest pain; - severe light headedness or dizziness; - rapid or irregular heartbeat.
Slovenian: Simptomi pljučne embolije (PE) lahko vključujejo: - nenadni pojav nepojasnjene kratke sape ali hitrega dihanja; - nenadno kašljanje, ki je lahko povezano s hemoptizo; - ostra bolečina v prsih; - huda vrtoglavica ali omotičnost; - hiter ali nepravilen srčni utrip.
English: Results from an EVRA study of extended wear of single contraceptive transdermal patch for 7 days and 10 days indicated that target Css of norelgestromin and ethinyl estradiol were maintained during a 3-day period of extended wear of EVRA (10 days).
Slovenian: Rezultati raziskav, v katerih so ženske posamezen kontracepcijski transdermalni obliž EVRA nosile dlje (7 in 10 dni) so pokazali, da so se med tridnevno podaljšano uporabo obliža EVRA (10 dni) ciljne Css norelgestromina in etinilestradiola ohranile.
English: EVRA 203 micrograms/24 hours + 33.9 micrograms/24 hours transdermal patch
Slovenian: EVRA 203 mikrogramov/24 ur + 33,9 mikrogramov/24 ur transdermalni obliž
English: EVRA has not been studied in women with renal impairment.
Slovenian: Obliža EVRA niso proučevali pri ženskah z okvaro ledvic.
English: • if you have an inflammation in the veins under the skin (superficial thrombophlebitis);
Slovenian: • če imate vnetje podkožnih žil (povrhnji tromboflebitis).
English: • Scaly, flaky, itchy and red skin
Slovenian: • luskasta, srbeča in rdeča koža
English: • sensation of squeezing or fullness in the chest, arm or below the breastbone;
Slovenian: • občutek stiskanja ali polnosti v prsih, rokah ali pod prsnico;
English: Study Group
Slovenian: Preučevana skupina
English: Each transdermal patch releases an average of 203 micrograms of NGMN and 33.9 micrograms of EE per 24 hours.
Slovenian: Iz vsakega transdermalnega obliža se povprečno sprostijo 203 mikrogrami NGMN in 33,9 mikrogramov EE v 24 urah.
English: How to start EVRA
Slovenian: Kako začeti z uporabo obliža EVRA
English: The transdermal patch should be pressed down firmly until the edges stick well.
Slovenian: Transdermalni obliž moramo močno pritisniti, da se robovi dobro nalepijo.
English: - Women with hypertriglyceridaemia, or a family history thereof, may be at an increased risk of pancreatitis when using combined hormonal contraceptives.
Slovenian: - Pri ženskah s hipertrigliceridemijo ali hipertrigliceridemijo v družinski anamnezi, ki jemljejo kombinirane hormonske kontraceptive, lahko obstaja zvečano tveganje za pankreatitis.
English: Studies have suggested that the incidence of VTE in women who used EVRA is up to 2-fold higher than in users of CHCs that contain levonorgestrel.
Slovenian: ki so uporabljale zdravilo EVRA, do 2-krat večja kot pri uporabnicah CHC, ki vsebujejo levonorgestrel.
English: If you take any of these medicines, you may need to use another method of birth control (such as a condom, diaphragm or foam).
Slovenian: Če jemljete katerega koli izmed zgoraj naštetih zdravil ali zdravil rastlinskega izvora, vam bo zdravnik lahko priporočil uporabo druge zanesljive kontracepcijske metode (kot je kondom, diafragma ali pena).
English: Limited data on the outcomes of exposed pregnancies in women using EVRA do not allow for conclusions about its safety during pregnancy.
Slovenian: Podatki o izidu nosečnosti pri ženskah, ki so bile izpostavljene obližem EVRA, na podlagi katerih bi lahko sklepali, da se med nosečnostjo le-ti lahko varno uporabljajo, so omejeni.
English: To dispose of used patch: place used patch so that the sticky side covers the shaded area remove backing paper close adhesive label and seal discard with solid waste
Slovenian: Ko želite zavreči uporabljen obliž: obliž položite tako, da lepljiva stran pokriva zasenčeni del. odstranite zaščitno folijo pokrijte in zalepite zavržite s smetmi
English: Seek urgent medical attention if you notice any of the following signs or symptoms.
Slovenian: Če opazite katerega od naslednjih znakov ali simptomov, poiščite nujno medicinsko pomoč.
English: Cancer, systemic lupus erythematosus, haemolytic uraemic syndrome, chronic inflammatory bowel disease (Crohn's disease or ulcerative colitis) and sickle cell disease.
Slovenian: Druga klinična stanja, povezana z VTE Rak, sistemski eritematozni lupus, hemolitično uremični sindrom, kronična vnetna črevesna bolezen (Crohnova bolezen ali ulcerozni kolitis) in srpastocelična bolezen.
English: There is no relevant use of EVRA in children and pre-menarchal adolescents.
Slovenian: Uporaba obliža EVRA pri otrocih in mladostnikih pred menarho ni primerna.
English: After 6 consecutive weeks of transdermal patch wear, there should be a transdermal patch-free interval of 7 days.
Slovenian: Šestim tednom neprekinjene uporabe obliža mora slediti 7 dnevni premor.
English: • Anger or feeling frustrated
Slovenian: • jeza, razdražljivost ali frustracija
English: If any of the above conditions change while you are using EVRA, for example a close family member experiences a thrombosis for no known reason; or you gain a lot of weight, tell your doctor.
Slovenian: Če se med uporabo zdravila EVRA kateri od zgoraj navedenih pogojev spremeni, na primer če dobi bližnji sorodnik trombozo zaradi neznanega razloga, ali če se močno zredite, posvetujte se z zdravnikom.
English: If you forget to change your patch
Slovenian: Če pozabite odstraniti obliž
English: • Put on the first patch of your new cycle as soon as you remember.
Slovenian: • Prvi obliž novega cikla namestite, takoj ko se spomnite.
English: Hormonal contraceptives may affect the metabolism of certain other active substances.
Slovenian: Hormonski kontraceptivi lahko vplivajo na presnovo določenih zdravilnih učinkovin.
English: Factors that increase your risk of a blood clot in a vein The risk of a blood clot with EVRA is small but some conditions will increase the risk.
Slovenian: Dejavniki, ki povečujejo tveganje krvnega strdka v veni Tveganje krvnega strdka z zdravilom [izmišljeno ime] je majhno, vendar nekatera stanja tveganje povečajo.
English: Cardiac disorders rare
Slovenian: Srčne bolezni redki
English: • You may start this medicine any day after stopping the progestogen-only pill or on the day of removal of an implant or when the next injection would be due.
Slovenian: • Obliž namestite prvi dan po prenehanju jemanja tablet s progestogenom, na dan odstranitve implantata ali ko bi morali dobiti naslednjo injekcijo.
English: EVRA acts through the mechanism of gonadotropin suppression by the estrogenic and progestational actions of ethinyl estradiol and norelgestromin.
Slovenian: Mehanizem delovanja obliža EVRA temelji na zaviranju gonadotropina, ki je posledica estrogenskega in progestagenskega delovanja etinilestradiola in norelgestromina.
English: - for more than two days (48 hours or more): The user may not be protected from pregnancy.
Slovenian: - več kot dva dni (48 ur ali več): Ženska lahko zanosi.
English: The user should apply the first transdermal patch of the new cycle as soon as remembered.
Slovenian: Prvi transdermalni obliž v novem ciklu mora namestiti takoj, ko se spomni.
English: In isolated cases, these tumours have led to life-threatening intra-abdominal haemorrhages.
Slovenian: V posameznih primerih so ti tumorji povzročili življenjsko nevarne krvavitve v trebušni votlini.
English: If during the 7 days preceding the first skipped day of transdermal patch application, the transdermal patch was worn correctly, no additional contraceptive use is required.
Slovenian: Če je transdermalni obliž uporabljala pravilno prvih 7 dni pred tistim dnem, ko ga je pozabila zamenjati, uporaba dodatne kontracepcije ni potrebna.
English: • Migraine
Slovenian: • migrena
English: • Check each day to make sure the patch has not fallen off.
Slovenian: • Vsak dan preverite, ali je obliž še vedno na svojem mestu.
English: Contains 1 transdermal patch
Slovenian: Vsebuje 1 transdermalni obliž.
English: • with increasing age (beyond about 35 years);
Slovenian: • s starostjo (zlasti po 35 letu);
English: • Do not use this medicine if you are breast-feeding or planning to breast-feed (see also section 2
Slovenian: • Na uporabite tega zdravila, če dojite ali nameravate dojiti (glejte tudi poglavje 2 Nosečnost in dojenje).
English: Therefore, EVRA-users must switch to an alternative method of contraception (e.g., progestagen-only contraception or non-hormonal methods) prior to starting therapy with this combination drug regimen.
Slovenian: Zato morajo uporabnice obliža EVRA pred zdravljenjem s to kombinacijo zdravil preiti na alternativno metodo kontracepcije (npr. samo na progestagen ali na nehormonsko metodo).
English: • If you start more than 4 weeks after delivery, use another non-hormonal contraceptive in addition to this medicine for the first 7 days.
Slovenian: • Če boste začeli uporabljati to zdravilo več kot 4 tedne po porodu, morate v prvih 7 dneh sočasno uporabljati še nehormonski kontraceptiv.
English: • if you are very overweight (body mass index or BMI over 30 kg/m
Slovenian: • če imate zelo prekomerno telesno maso (indeks telesne mase (ITM) čez 30 kg/m2);
English: Janssen Pharmaceutica NV, Turnhoutseweg 30, B-2340 Beerse, Belgium
Slovenian: Janssen Pharmaceutica NV, Turnhoutseweg 30, Beerse B-2340, Belgija
English: There is no consensus about the possible role of varicose veins and superficial thrombophlebitis in the onset or progression of venous thrombosis.
Slovenian: O možni vlogi varikoznih ven in povrhnjega tromboflebitisa pri nastanku ali napredovanju venske trombembolije ni enotnega mnenja.
English: This usually happens in the first 3 months and especially if your periods were not regular before you started using this medicine.
Slovenian: Ko prenehate uporabljati obliž EVRA, imate, predvsem prve 3 mesece, lahko neredne ali šibke menstruacije ali pa jih sploh nimate, zlasti če vaša menstruacija, že preden ste začeli uporabljati to zdravilo, ni bila redna.
English: • if you need an operation or if you are off your feet for a long time (see section ‘Blood clots )';
Slovenian: • če potrebujete kirurški poseg ali če ste dalj časa nepokretni (glejte poglavje "Krvni strdki")
English: If you want to delay your period, apply a patch at the beginning of Week 4 (Day 22) instead of not wearing a patch on Week 4.
Slovenian: Če želite preložiti menstruacijo, morate naslednji obliž namestiti na začetku 4. tedna (22. dan) in ne upoštevati premora.
English: If there is no withdrawal bleeding within 5 days of the last active (hormone containing) tablet, pregnancy must be ruled out prior to the start of treatment with EVRA.
Slovenian: Če se v petih dneh po zaužitju zadnje tablete z učinkovino prekinitvena krvavitev ne pojavi, moramo pred začetkom uporabe obliža EVRA izključiti nosečnost.
English: Steady state concentrations of norelgestromin and EE during one week of transdermal patch wear are approximately 0.8 ng/ml and 50 pg/ml, respectively.
Slovenian: Po enem tednu uporabe transdermalnega obliža koncentracije norelgestromina in etinilestradiola v stanju dinamičnega ravnovesja znašajo približno 0,8 ng/ml oz. 50 pg/ml.
English: If breakthrough bleeding persists, or breakthrough bleeding occurs after previously regular cycles, while EVRA has been used according to the recommended regimen, a cause other than EVRA should be considered.
Slovenian: Če se po ciklih, ki so bili v preteklosti redni, krvavitev kljub predpisanem odmerku ne ustavi, oz. se le-ta pojavi, čeprav je ženska obliže EVRA uporabljala po priporočenem režimu, moramo razmisliti o drugem vzroku.
English: A sachet is composed of four layers: a low-density polyethylene film (innermost layer), an aluminium foil, a low-density polyethylene film, and an outer layer of bleached paper.
Slovenian: Blazinica sestoji iz štirih plasti: film iz polietilena nizke gostote (skrajna notranja plast), aluminijasta folija, film iz polietilena nizke gostote, in zunanja plast iz beljenega papirja.
English: Application site reactions* (e.g., abscess, erosion) Localised oedema*
Slovenian: redki edem obraza* vtisni edem* oteklina reakcije namestu aplikacije* (e.g., absces, erozije) lokaliziran edem*
English: In some women withdrawal bleeding may not occur during this transdermal patch free period.
Slovenian: Pri nekaterih ženskah se med premorom prekinitvena krvavitev ne pojavi.
English: An increased risk of arterial and venous thrombotic and thrombo-embolic events, including myocardial infarction, stroke, transient ischemic attacks, venous thrombosis and pulmonary embolism has been observed in women using CHCs, which are discussed in more detail in section 4.4.
Slovenian: Pri ženskah, ki uporabljajo CHC, so opazili povečano tveganje arterijskih in venskih trombotičnih in trombemboličnih dogodkov, vključno z miokardnim infarktom, možgansko kapjo, prehodnimi ishemičnimi napadi, vensko trombozo in pljučno embolijo, ki so bolj podrobno obravnavani v poglavju 4.4.
English: Data on reproductive toxicity of the combination of norelgestromin with ethinyl estradiol are not available.
Slovenian: Podatkov o vplivu kombinacije norelgestromina in etinilestradiola na sposobnost razmnoževanja ni.
English: • if you need an operation, or you are off your feet for a long time (see in section 2 ‘Blood clots');
Slovenian: • če potrebujete kirurški poseg ali če ste dalj časa nepokretni (glejte poglavje 2 "Krvni strdki".
English: • Put it on the buttock, abdomen, upper outer arm or upper back places where it won't be rubbed by tight clothing
Slovenian: • Namestite ga na zadnjico, trebuh, zunanjo stran nadlahti ali zgornji del hrbta, in sicer na takšno mesto, da se obenj ne bodo drgnila tesna oblačila.
English: Overdose may cause nausea or vomiting.
Slovenian: Prevelik odmerek lahko povzroči slabost ali bruhanje.
English: • if you have ever been told you might have breast cancer or cancer of the womb, cervix or vagina;
Slovenian: • če je kdaj obstajal sum, da bi lahko imeli raka dojke, maternice, materničnega vratu, ali nožnice
English: • Presence or risk of venous thromboembolism (VTE)
Slovenian: • Prisotnost ali tveganje za vensko trombembolijo (VTE)
English: • If you need a blood or urine test, tell your doctor or the laboratory staff that you are taking
Slovenian: • Če vam bodo pregledali kri ali urin, zdravniku ali osebi, ki jemlje vzorec, povejte, da uporabljate obliž EVRA.
English: Manufacturer: Janssen Pharmaceutica NV, Turnhoutseweg 30, B-2340 Beerse, Belgium.
Slovenian: Izdelovalec: Janssen Pharmaceutica NV, Turnhoutseweg 30, Beerse B-2340, Belgija.
English: Do not wear a patch on Week 4 (Day 22 through Day 28).
Slovenian: 4. teden (22. do 28. dan) obliža ne uporabljajte.